Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cardlytics, Inc. - Common Stock (NQ:CDLX)

0.9271 +0.0161 (+1.77%)
Streaming Delayed Price Updated: 11:13 AM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cardlytics, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday ↗
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results. 
Via Benzinga
News headline image
Here's Why Cardlytics Stock Sank to an All-Time Low on Wednesday ↗
The business trends are worse than management expected. 
Via The Motley Fool
News headline image
Cardlytics Sees Price Target Cut By 26% To Reflect Macro Headwinds ↗
 
Via Benzinga
News headline image
What 7 Analyst Ratings Have To Say About Cardlytics ↗
Cardlytics (NASDAQ:CDLX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Cardlytics Announces Third Quarter 2022 Financial Results
From Cardlytics, Inc.
Via GlobeNewswire
News headline image
Cardlytics Announces Timing of Its Third Quarter 2022 Financial Results Conference Call and Webcast
From Cardlytics, Inc.
Via GlobeNewswire
News headline image
10 Communication Services Stocks Moving In Monday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
11 Communication Services Stocks Moving In Friday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
Where Cardlytics Stands With Analysts ↗
Analysts have provided the following ratings for Cardlytics (NASDAQ:CDLX) within the last quarter: 
Via Benzinga
News headline image
Recap: Cardlytics Q2 Earnings ↗
Cardlytics (NASDAQ:CDLX) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Where Cardlytics Stands With Analysts ↗
Cardlytics (NASDAQ:CDLX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday ↗
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case. 
Via Benzinga
News headline image
Why Bank of America Shares Are Trading Higher? Here Are 66 Stocks Moving In Monday's Mid-Day Session ↗
Gainers FedNat Holding Company (NASDAQ: FNHC) shares rose 78.9% to $0.93 after jumping 48% on Friday. 
Via Benzinga
News headline image
11 Communication Services Stocks Moving In Monday's Intraday Session ↗
  
Via Benzinga
News headline image
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday ↗
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  During Friday's session, 61 companies made new 52-week lows. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022 ↗
  
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  During Thursday's trading, 50 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 100 companies reached new 52-week lows. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
Friday's session saw 47 companies set new 52-week lows. 
Via Benzinga
News headline image
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday ↗
Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media. 
Via Benzinga
News headline image
A Look At Needham's Top FinTech Picks ↗
After another earnings season and coming off the 17th Annual NTMC, Needham analyst Mayank Tandon received updates from its entire coverage universe in recent weeks. 
Via Benzinga
News headline image
Tesla, Twitter And 76 Biggest Movers From Friday ↗
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board... 
Via Benzinga
News headline image
Cardlytics: Q1 Earnings Insights ↗
Cardlytics (NASDAQ:CDLX) reported its Q1 earnings results on Monday, May 2, 2022 at 05:00 PM. Here's what investors need to know about the announcement. Earnings Cardlytics beat estimated earnings by... 
Via Benzinga
News headline image
Earnings Scheduled For May 2, 2022 ↗
Companies Reporting Before The Bell • New Gold (AMEX:NGD) is estimated to report quarterly earnings at $0.03 per share on revenue of $212.42 million. 
Via Benzinga
News headline image
Earnings Outlook For Cardlytics ↗
Cardlytics (NASDAQ:CDLX) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Cardlytics will... 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.